FDFT1 and urinary bladder cancer: Apart from being highly expressed in cisplatin-sensitive bladder cancer cell lines compared to its resistant counterpart, knockdown of FDFT1 in bladder cancer cells has resulted in acquisition of mesenchymal morphology and increased vimentin expression [12].